Syneos Health Completes Acquisition of Synteract
10 déc. 2020 08h59 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
07 déc. 2020 17h18 HE
|
Syneos Health, Inc.
Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
03 déc. 2020 08h49 HE
|
Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
Syneos Health Announces Secondary Offering of Common Stock
01 déc. 2020 16h21 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029
24 nov. 2020 18h07 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029
18 nov. 2020 18h52 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer
17 nov. 2020 08h40 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A....
Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020
16 nov. 2020 08h43 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health to Present at Upcoming Investor Conferences
02 nov. 2020 17h20 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health Reports Third Quarter 2020 Results
29 oct. 2020 06h13 HE
|
Syneos Health, Inc.
Highlights Announced agreement to acquire Synteract, a mid-sized, full-service CRO focused on the fast growing emerging biopharma sector.GAAP revenue of $1,099.0 million for the three months ended...